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The truth is sobering. The world is struggling to even comprehend, much less contain, the coronavirus disease 2019 (COVID‐19) pandemic. As I write this on Monday, May 25, 2020, Memorial Day, there are more than 5.4 million cases of confirmed COVID‐19 globally, with more than 1.6 million cases reported in the United States alone. Greater than 350,000 people have died of the disease across the globe, with the death rate in the United States alone approaching 100,000, resulting in 40,000 more American deaths than those caused by the 2 decades--long Vietnam war. And infection rates in Brazil, Russia, and India are cresting even as the disease continues to run its awful course across Europe.

The effects on the global economy have been especially terrible. In February, before the first cases were confirmed in the United States, unemployment stood at a near record low of 3.6%. Over the course of 3 devastating months, greater than 40 million Americans will have lost their jobs by the time May ends, and the greatest global recession since the Great Depression continues to accelerate. With economic devastation accompanying the health catastrophe, the whole world, with very few exceptions, has become one endless front line in the war against COVID‐19.

Here in Lebanon, an unpopular government, working with a vigorous public hospital leadership and more than one dozen cooperative and collegial academic and private hospitals, has seen the spread of the virus contained at approximately 1100 cases, with 26 deaths so far. This is despite failing to make its debt payments for the first time in the nearly 100‐year history of the Lebanese Republic and attempting to negotiate financial receivership with the International Monetary Fund, although so far unsuccessfully.

The contrast is astonishing. The United States, the greatest economic and military power in the world, will tragically lose greater than 100,000 lives, and is failing badly to control COVID‐19 with its incalculable health and economic consequences, while a politically corrupt and economically bankrupt country, formerly an upwardly mobile middle‐income state, has reported 26 deaths over 3 months. Why have the 2 countries so far demonstrated such markedly different results with regard to the containment of COVID‐19? This despite grossly inadequate testing in Lebanon, a country that is struggling to run 1500 tests for COVID‐19 per day, even now. Why are the results so different, particularly the death rates? What happened? What can we learn from this? Finally, how do we take those lessons forward to piece together a more livable, equitable world in this setting?

The reasons behind Lebanon\'s low death rates are complex, but suffice to say that the country stumbled into early closure because of fear and mistrust of the same ineffectual Lebanese government that somehow has managed to play a role in keeping the death rates low. After a grand total of 6 cases were documented in Lebanon, the government pressured all public and private schools and universities to close down, assuming that early closure of the educational sector would have a significant effect in reducing viral transmission. This led to talks with the government in which school and university leadership, backed by advice from international and local experts in infectious disease and epidemiology, steadily and consistently indicated that closure of this sector alone represented a grossly inadequate and largely ineffectual approach. But something significant happened. The people panicked and started to shelter in place, fueled by their distrust of the government and its ability to manage the pandemic, with the government then picking up on this and gradually closing down the entire country. Although this is not sustainable, in a country in which unemployment already has exceeded 50%, for a population of approximately 6 million individuals, including approximately 2 million Syrian and Palestinian refugees, 26 deaths over 3 months represents a scarcely believable number. The degree of fear of COVID‐19 among the population is such that Lebanese doctors outside the physician practice of the American University of Beirut have seen approximately 10% of their previous volumes of patients over the last 3 months. Although the volume at the University I lead is closer to 40%, it is curious to note that the cancer patient treatment volume is nearly at 80% of pre--COVID‐19 levels. Therein lies the valuable lesson.

Clearly, fear of COVID‐19 is exceeded by fear of cancer, at least among our population, and as we have been reporting in various COVID‐19--specific articles over the last few months, that pattern appears generally to be holding worldwide. Although the rates of elective procedures and even cardiovascular visits are down substantially, oncologists of all specialties have been working to come up with new approaches to keep patients with cancer, who are particularly vulnerable to COVID‐19 and other viral infections because their immune systems are compromised, on course for their treatments, be this surgery, chemotherapy, immunotherapy, or radiation. Using telemedicine increasingly for appointments with asymptomatic patients, and carefully distanced encounters with laboratory and imaging tests obtained in such a manner as to keep patients, their families, and others apart, with visiting hours all but proscribed for patients during this era, the system continues to serve patients with cancer reasonably well so far, with no early reports of worse outcomes for patients in large or small health systems. Important social distancing innovations and the use of personal protective equipment have been incorporated, but clearly, cancer is among the few diseases for which patients are not comfortable delaying their treatments until this pandemic runs its course.

The same seems to be the case with regard to articles and submissions for our journal, *Cancer*. Although the number of submissions has been increasing steadily for the last 3 years, with record numbers of submissions year on year, the last 3 months have been astounding. March, April, and May will have seen greater than 350, greater than 370, and 400, respectively, peer‐reviewed articles submitted to *Cancer*, an increase from last year\'s already record pace of nearly 15%. And unlike other journals, a tiny minority of submissions to *Cancer* are articles about COVID‐19.

All of this leads me to conclude that although COVID‐19 indeed has stolen all the headlines, cancer treatment, care, and research continue apace in this brave, new, Zoom‐ and WebEx‐powered world. And the cancer front, at the very least, appears to be holding, waiting for the rest of the world to catch up.
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